Doseology Sciences (VU70) Financial Statements
Doseology Sciences Financial Overview
Doseology Sciences's market cap is currently $434.88K. The company's EPS TTM is $-0.08; its P/E ratio is -0.57; Doseology Sciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 25 | Sep 24 | Sep 23 | Sep 22 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 42.56K | $ 98.52K | $ 43.09K | $ 16.05K | $ 0.00 |
| Gross Profit | $ 18.89K | $ 72.09K | $ 41.29K | $ -148.38K | $ -92.83K |
| Operating Income | $ -471.61K | $ -377.63K | $ -832.17K | $ -1.82M | $ -1.56M |
| EBITDA | $ -471.61K | $ -319.48K | $ -1.78M | $ -1.72M | $ -1.47M |
| Net Income | $ -447.79K | $ -339.85K | $ -1.78M | $ -1.94M | $ -1.63M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.43M | $ 1.06M | $ 1.30M | $ 1.87M | $ 3.73M |
| Total Assets | $ 1.49M | $ 1.10M | $ 1.40M | $ 3.87M | $ 5.99M |
| Total Debt | $ 0.00 | $ 0.00 | $ 50.27K | $ 746.10K | $ 687.54K |
| Net Debt | $ -1.43M | $ -1.06M | $ -1.25M | $ -1.13M | $ -3.05M |
| Total Liabilities | $ 94.11K | $ 82.49K | $ 99.19K | $ 871.51K | $ 3.41M |
| Stockholders' Equity | $ 1.40M | $ 1.02M | $ 1.30M | $ 3.00M | $ 2.58M |
| Cash Flow | |||||
| Free Cash Flow | $ -342.24K | $ -235.12K | $ -481.05K | $ -1.72M | $ -2.54M |
| Operating Cash Flow | $ -342.24K | $ -235.12K | $ -481.05K | $ -1.71M | $ -2.37M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ -7.88K | $ -26.05K |
| Financing Cash Flow | $ 711.68K | $ -6.14K | $ -91.88K | $ -140.08K | $ 5.79M |
Currency in CAD